Floatz logo

Quadrivalent Inactivated Influenza Vaccine

Congestive Heart Failure

Kaiser PermanentevaccineDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Congestive Heart Failure cohort.

Asset / SponsorPhaseRating
VALSARTAN
Kyoto Prefectural University of Medicine
Phase 4BB
Dilatrend Sr
Chong Kun Dang Pharmaceutical
Phase 1CC
Dilatrend
Chong Kun Dang Pharmaceutical
Phase 1CC
Flublok Quadrivalent
Kaiser Permanente
D

Same molecule, other indications

Quadrivalent Inactivated Influenza Vaccine is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
69 / 100
View asset →
viral infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →
lung cancerDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →